Fulgent Genetics (FLGT) Competitor Comparison
We are evaluating the key criteria listed to compare Fulgent Genetics (FLGT) against its competitors in the Diagnostics & Research industry.
Market Capitalization
34 / 58Gross Profits
24 / 52Total Revenue
31 / 57EBITDA
41 / 56Free Cashflow
22 / 56Quick Ratio
5 / 57Earnings per Share
55 / 56Dividend yield
0 / 9Total Cash
15 / 57Performance 3 years
45 / 58Performance 5 years
20 / 58Performance 10 years
24 / 58Linearity 3 years
42 / 58Linearity 5 years
9 / 58Linearity 10 years
9 / 58Total Rank
45 / 58Dividend Rank
20 / 58Valuation Rank
36 / 58Piotroski Rank
25 / 58Muliplier Rank
21 / 58Total Rank - FLGT ranking 45 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.